CoChat
Sign Up
Cited by 108

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

The miRNome of Alzheimer's disease: consistent downregulation of the miR-132/212 cluster

Pichler, Sabrina, Gu, Wei, Hartl, Daniela, Gasparoni, Gilles, Leidinger, Petra, Keller, Andreas, Meese, Eckart, Mayhaus, Manuel, Hampel, Harald, Riemenschneider, Matthias·2017·Neurobiology of Aging
DOI 10.1016/j.neurobiolaging.2016.09.019
Open this paper in CoChat — free account

Abstract

MicroRNAs (miRNAs) are small noncoding RNA molecules, with essential functions in RNA silencing and post-transcriptional regulation of gene expression. miRNAs appear to regulate the development and function of the nervous system. Alterations of miRNA expression have been associated with Alzheimer's disease (AD). To characterize the AD miRNA signature, we examined genome-wide miRNA and mRNA expression patterns in the temporal cortex of AD and control samples. We validated our miRNA results by semiquantitative real-time polymerase chain reaction (PCR) in independent prefrontal cortex. Furthermore, we separated gray and white matter brain sections to identify the cellular origin of the altered miRNA expression. We observed genome-wide downregulation of hsa-miR-132-3p and hsa-miR-212-3p in AD with a stronger decrease in gray matter AD samples. We further identified 10 differently expressed transcripts achieving genome-wide levels of significance. Significantly deregulated miRNAs and mRNAs were correlated and examined for potential binding sites (in silico). This miRNome-wide study in AD provides supportive evidence and corroborates an important contribution of miR-132/212 and corresponding target mRNAs to the pathogenesis of AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.neurobiolaging.2016.09.019

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 40

  1. Ascolani, 2012, Dysregulated NF-κB pathway in peripheral mononuclear cells of Alzheimer's disease patients, Curr. Alzheimer Res., 9, 128, 10.2174/156720512799015091 · DOI
  2. Audas, 2008, A novel protein, Luman/CREB3 recruitment factor, inhibits Luman activation of the unfolded protein response, Mol. Cell. Biol., 28, 3952, 10.1128/MCB.01439-07 · DOI
  3. Bartel, 2004, MicroRNAsGenomics, biogenesis, mechanism, and function, Cell, 116, 281, 10.1016/S0092-8674(04)00045-5 · DOI
  4. Bicker, 2014, MicroRNA-132, -134, and -138: a microRNA troika rules in neuronal dendrites, Cell. Mol. Life Sci, 71, 3987, 10.1007/s00018-014-1671-7 · DOI · Paper page
  5. Buchser, 2010, Kinase/phosphatase overexpression reveals pathways regulating hippocampal neuron morphology, Mol. Syst. Biol., 6, 391, 10.1038/msb.2010.52 · DOI
  6. Dweep, 2011, miRWalk–database: prediction of possible miRNA binding sites by “walking” the genes of three genomes, J. Biomed. Inform., 44, 839, 10.1016/j.jbi.2011.05.002 · DOI
  7. Griffiths-Jones, 2006, miRBase: microRNA sequences, targets and gene nomenclature, Nucleic Acids Res., 34, D140, 10.1093/nar/gkj112 · DOI · Paper page
  8. Hales, 2014, Aggregates of small nuclear ribonucleic acids (snRNAs) in Alzheimer's disease, Brain Pathol., 24, 344, 10.1111/bpa.12133 · DOI · Paper page
  9. Hancock, 2014, MicroRNA-132 is enriched in developing axons, locally regulates Rasa1 mRNA, and promotes axon extension, J. Neurosci., 34, 66, 10.1523/JNEUROSCI.3371-13.2014 · DOI · Paper page
  10. Hébert, 2008, Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression, Proc. Natl. Acad. Sci. U. S. A., 105, 6415, 10.1073/pnas.0710263105 · DOI · Paper page
  11. Hébert, 2012, MicroRNAs and the regulation of tau metabolism, Int. J. Alzheimers Dis., 2012, 406561
  12. Hébert, 2013, A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls, J. Alzheimers Dis., 35, 335, 10.3233/JAD-122350 · DOI · Paper page
  13. Hernandez-Rapp, 2015, Memory formation and retention are affected in adult miR-132/212 knockout mice, Behav. Brain Res., 287, 15, 10.1016/j.bbr.2015.03.032 · DOI · Paper page
  14. Huang, 2005, NF-kappaB precursor, p105, and NF-kappaB inhibitor, IkappaBgamma, are both elevated in Alzheimer disease brain, Neurosci. Lett., 373, 115, 10.1016/j.neulet.2004.09.074 · DOI
  15. Ingelsson, 2004, Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain, Neurology, 62, 925, 10.1212/01.WNL.0000115115.98960.37 · DOI · Paper page
  16. Kolbert, 2013, Multi-platform analysis of MicroRNA expression measurements in RNA from fresh frozen and FFPE tissues, PLoS One, 8, e52517, 10.1371/journal.pone.0052517 · DOI
  17. Krüger, 2006, RNAhybrid: microRNA target prediction easy, fast and flexible, Nucleic Acids Res., 34, W451, 10.1093/nar/gkl243 · DOI · Paper page
  18. Lau, 2013, Alteration of the microRNA network during the progression of Alzheimer's disease, EMBO Mol. Med., 5, 1613, 10.1002/emmm.201201974 · DOI · Paper page
  19. Lau, 2014, Variance in the identification of microRNAs deregulated in Alzheimer's disease and possible role of lincRNAs in the pathology: the need of larger datasets, Ageing Res. Rev., 17, 43, 10.1016/j.arr.2014.02.006 · DOI
  20. Liu, 2012, MicroRNA-16 targets amyloid precursor protein to potentially modulate Alzheimer's-associated pathogenesis in SAMP8 mice, Neurobiol. Aging, 33, 522, 10.1016/j.neurobiolaging.2010.04.034 · DOI
  21. Livak, 2001, Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method, Methods, 25, 402, 10.1006/meth.2001.1262 · DOI · Paper page
  22. Lu, 2013, Synaptic acetylcholinesterase targeted by microRNA-212 functions as a tumor suppressor in non-small cell lung cancer, Int. J. Biochem. Cell Biol., 45, 2530, 10.1016/j.biocel.2013.08.007 · DOI
  23. Lukiw, 2012, Studying micro RNA function and dysfunction in Alzheimer's disease, Front. Genet., 3, 327
  24. Magill, 2010, microRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus, Proc. Natl. Acad. Sci. U. S. A., 107, 20382, 10.1073/pnas.1015691107 · DOI · Paper page
  25. McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
  26. Nagele, 2004, Contribution of glial cells to the development of amyloid plaques in Alzheimer's disease, Neurobiol. Aging, 25, 663, 10.1016/j.neurobiolaging.2004.01.007 · DOI
  27. Nelson, 2010, MiR-107 is reduced in Alzheimer's disease brain neocortex: validation study, J. Alzheimers Dis., 21, 75, 10.3233/JAD-2010-091603 · DOI · Paper page
  28. Nunez-Iglesias, 2010, Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation, PLoS One, 5, e8898, 10.1371/journal.pone.0008898 · DOI
  29. Rehmsmeier, 2004, Fast and effective prediction of microRNA/target duplexes, RNA, 10, 1507, 10.1261/rna.5248604 · DOI · Paper page
  30. Remenyi, 2013, miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity, PLoS One, 8, e62509, 10.1371/journal.pone.0062509 · DOI · Paper page
  31. Satoh, 2012, Molecular network of microRNA targets in Alzheimer's disease brains, Exp. Neurol., 235, 436, 10.1016/j.expneurol.2011.09.003 · DOI
  32. Shaked, 2009, MicroRNA-132 potentiates cholinergic anti-inflammatory signaling by targeting acetylcholinesterase, Immunity, 31, 965, 10.1016/j.immuni.2009.09.019 · DOI · Paper page
  33. Shaltiel, 2013, Hippocampal microRNA-132 mediates stress-inducible cognitive deficits through its acetylcholinesterase target, Brain Struct. Funct., 218, 59, 10.1007/s00429-011-0376-z · DOI
  34. Smith, 2011, MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy, Hum. Mol. Genet., 20, 4016, 10.1093/hmg/ddr330 · DOI · Paper page
  35. Soreq, 2011, NeurimmiRs: microRNAs in the neuroimmune interface, Trends Mol. Med., 17, 548, 10.1016/j.molmed.2011.06.009 · DOI · Paper page
  36. Vorwerk, 2008, Microfluidic-based enzymatic on-chip labeling of miRNAs, N. Biotechnol., 25, 142
  37. Wanet, 2012, miR-212/132 expression and functions: within and beyond the neuronal compartment, Nucleic Acids Res., 40, 4742, 10.1093/nar/gks151 · DOI
  38. Wang, 2011, Patterns of microRNA expression in normal and early Alzheimer's disease human temporal cortex: white matter versus gray matter, Acta Neuropathol., 121, 193, 10.1007/s00401-010-0756-0 · DOI · Paper page
  39. Wong, 2013, De-repression of FOXO3a death axis by microRNA-132 and -212 causes neuronal apoptosis in Alzheimer's disease, Hum. Mol. Genet., 22, 3077, 10.1093/hmg/ddt164 · DOI · Paper page
  40. Yang, 2013, Expression pattern implicates a potential role for luman recruitment factor in the process of implantation in uteri and development of preimplantation embryos in mice, J. Reprod. Dev., 59, 245, 10.1262/jrd.2012-137 · DOI

Cited by

Sorted by citations

Metadata

Authors
Pichler, S., Gu, W., Hartl, D., Gasparoni, G., Leidinger, P., Keller, A., Meese, E., Mayhaus, M., Hampel, H., & Riemenschneider, M.
Venue
Neurobiology of Aging
Publisher
Elsevier BV
Published
2017-02
Volume
50
Pages
167.e1-167.e10
ISSN
0197-4580
DOI
10.1016/j.neurobiolaging.2016.09.019
Cited by
108
References
5
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Funders
  • German Federal Ministry of Education and Research
  • National Genome Research Network (01GS08125)
  • Helmholtz Alliance for Mental Health in an Aging Society (Ha-15)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review